Oser Communications Group

NACDS.TSE17.Aug22

Issue link: http://osercommunicationsgroup.uberflip.com/i/858133

Contents of this Issue

Navigation

Page 53 of 63

Chain Drugstore Daily Tuesday, August 22, 2017 5 4 reinvesting earnings into R&D from the very start, Amneal now finds itself with an expansive, diverse product portfolio and pipeline combined. The company anticipates launching more than 60 products in the U.S. this year, including some exciting first-to-file and first-to-market products, along with new dosage-forms for Amneal. It all adds up to good news for Amneal customers – and ultimately, the millions of patients who count on the quality, integrity and value built into each and every Amneal product. "Our company's success is enabled by our sharp focus on growth strategy along with significant investments in R&D and infrastructure," explains Jim Luce, Amneal Executive Vice President, Sales and Marketing. With a laser focus on providing superb quality products across all dosage forms, Amneal's momentum is strong. As one of the top 10 generic manufacturers in the U.S., by prescription volume, and the fastest-growing global generics com- pany (QuintilesIMS), Amneal maintains powerful R&D, efficient production, strategic sourcing and a fine-tuned sales operations/logistics engine to fuel its mission. From the start, Amneal has rein- vested heavily, with a disproportionate percentage of its revenue, in growing and broadening its product portfolio across all dosage forms and numerous therapeutic categories. Simultaneously, it continues to expand and enhance infrastructure in order to comfortably service future growth, thus ensuring the Amneal (Cont'd. from p. 1) capacity to meet anticipated product approvals. "From the early days of our com- pany, there's been an unrelenting com- mitment to quality, both measurably by FDA criteria and attitudinally throughout all areas of our organiza- tion," added Luce. "Since the begin- ning, we've had 57 inspections with- out any significant 483s across our 10 FDA-approved facilities. This com- mitment to quality stems from our guiding principle to view the con- sumer of our products as a family member. Would you give your family anything but the very best? This belief permeates throughout our organiza- tion, instilling great confidence among our customers and our mutual cus- tomer, the patient." One thing is clear: there is no single aspect of Amneal that drives the compa- ny's value. It's the entire team – the sci- entists, engineers, operations, sales and logistics – that maximizes value for its customers. According to Luce, "We believe by focusing on our customers and patients, and standing by the values of quality and integrity, this path will allow us to con- tinue sustaining our dramatic growth for years to come." Today, more than ever, Amneal is the name you can trust for today's generic pharmaceuticals. Delivering a constant stream of high-quality products, Amneal strengthens health, wellness and better quality of life for people around the globe. For more information, visit booth #2029 or go to www.amneal.com. strict quality. "We make sure we are at the fore- front of the industry that serves more than 80 percent of the population by edu- cating consumers," says Vice President of Sales and Marketing, Manny Favela. "Along with that, we provide the safest and most innovative products available." Since 1976, Studex has been at the apex of manufacturing and designing ear piercing systems and allergy free fashion earrings. The combination of dedication and innovation has helped Studex to leap over competitors to become the world's largest manufacturer of ear piercing instruments, studs and supplies. Studex is uncompromising in com- mitment to quality and service as all products exceed U.S. FDA regulations and EC Standards. With 40-plus offices worldwide, it strives to provide cus- tomers with the highest-quality products, as well as marketing and sales assistance to sustain their success. The Studex sales team brings years of experience that can have a dramatic impact providing valuable information regarding ear piercing service. "This is done with the no-cost point-of-purchase information and displays we provide for each location," Favela explains. "We offer comprehensive information that will answer most of the consumer's questions, and this establishes an ele- ment of trust that is vital in putting the consumer at ease regarding this serv- ice." Further reinforcing its reputation for quality is the fact that Studex prod- ucts are made in the USA and sterilized, with accurate spore testing and routine sterility tests. The Studex Universal Ear Piercing Studex (Cont'd. from p. 1) System is the most widely used ear piercing system in the world today. Millions of consumers around the world trust Studex Universal for safe and gentle piercing. The contoured handle and superior quality of the instrument assure years of trouble-free ear piercing. As an example of the company's efficacy, Favela points to the System 75, which was designed as an easy-to-use, disposable cartridge ear piercing system to meet the demands of professionals. The Studex System 75 uses a touch-free method for loading and disposal of used pierc- ing stud cartridges, providing safe, sterile piercing and it is designed to fit comfortably in hands of all sizes for accurate piercing. Studex System 75 products are available in stainless steel, titanium and 10K, 14K and 18K gold. The company has also developed a line of genuine dia- mond studs in 14 karat gold utilizing a Tiffany setting. Along with the most sought-after styles, Studex, with its in- house design team, is constantly on the cutting edge of fashion, developing new and exciting styles appealing to even the most finicky of tastes. Responding to market demand, Studex also developed Studex Sensitive, the high-fashion earring solution for peo- ple who suffer from nickel sensitivity. Each classic style is made of the highest- quality surgical stainless steel and 24 karat gold. Each style is guaranteed to be safe enough to be worn every day. "We provide earrings you can trust!" says Favela. Visit Studex at booth #3315. For more information, go to www.studex.com or call 310.851.9300. these moments of forgetfulness and don't know what to do about them. For moments like these and overall brain health, Natrol, the No. 1 brand of mela- tonin and one of the nation's leading vita- mins and supplements brands, recently launched a new supplement for brain health: Natrol Cognium. The product is specifically formulated to keep your mind sharp and your memory strong. Backed by nine human clinical studies, the active ingredient in Natrol Cognium has shown statistically significant improvements in memory and cognition in as little as four weeks. "People are used to taking supple- ments to help take care of their hearts, digestion and sleep issues, so it only makes sense they would look for some- thing to help improve their brain health. In fact, brain health isn't just something that's on the mind of baby boomers, I get questions about it from people of all ages," said Dr. Mike Dow, New York Times best-selling author of "The Brain Fog Fix." "There are many things that people can do to improve their health and one of those things can be taking Natrol Cognium, which is safe, natural and stim- ulant-free." Natrol Cognium is formulated using a unique protein found in silk as its active ingredient. The clinically proven protein works by energizing and protecting the Natrol (Cont'd. from p. 1) brain. This protein has been used safely in Eastern medicine for hundreds of years and proven safe and effective. The pro- tein in Natrol Cognium has been shown in clinical imaging to increase glucose, providing energy and nourishment for improved brain functioning. It also acts like an antioxidant for the brain, protect- ing it from free radicals and oxidation that cause aging. "We're excited to launch Natrol Cognium to address an important need for our consumers," said Thomas Hart, Marketing Director at Natrol. "From forgetting names at a party, to struggling for a word or remembering where you left your keys, these are moments we call can all identify with and wish we had something to keep our memory strong and our minds sharp. What makes Natrol Cognium unique and different is that it's the only brain health supple- ment supported by nine human clinical studies to improve memory and concen- tration. The science is strong and we are investing significantly to introduce Cognium to consumers and support our retail partners with the launch. It's an exciting innovation and an important addition to our growing portfolio of products focused on helping them proactively manage their everyday health and wellness." Visit Natrol at booth #3345. For more information, go to www.natrol.com. 125,000 deaths. Apparently, C. Everett Koop was right when he said, "Drugs don't work in patients who don't take them." The dilemma remains: how do phar- macies contribute to increasing patient adherence in an efficient manner that does not send costs through the roof? Pharmacies have relied heavily on auto- mated patient communications, including inbound IVR, outbound notifications, web/mobile applications, MedSync and scheduling solutions for immunizations and screenings. However, employing multiple vendors can cause confusion for patients, additional work for pharmacy staff and the potential for violations of the FCC TCPA and FTC TSR regula- tions. MarkeTouch Media is the only U.S. vendor in the industry that pro- vides holistic patient communication services without utilizing third party vendors or outsourced programmers. The benefits of using MarkeTouch's RxTouch suite of services include: consistent scripting, voices and inter- faces for communicating with patients; a single portal, allowing pharmacy staff to view all patient communication and reporting through one URL; and a single vendor, reducing security con- MarkeTouch (Cont'd. from p. 1) cerns related to data transmissions. In addition to providing consistent messaging through automation, phar- macies are increasing personal commu- nication between staff and patients. In its annual report card, NCPA deter- mined that "the leading indicator of whether a patient will adhere to their medication is their personal relation- ship with the pharmacist or pharmacy staff." MarkeTouch's unique service, Pharmacist Connect, allows pharmacy staff to increase patient communication without affecting workflow. A pharma- cy staff member logs in to the portal (the same, single portal used for auto- mated messaging), views patient histo- ry, medications, adherence information and potential interventions and makes calls without dialing the phone. The service has proven to increase patient adherence to their medication regimens; results include Return to Stock reduced by 20 percent over traditional automa- tion, increasing PDC scores by 30 per- cent and more than 50 percent enroll- ment into MedSync. It's clear that a single source for all patient communications increases phar- macy revenue, patient adherence and sat- isfaction. For more information, visit booth #1845 or go to www.rxtouch.com.

Articles in this issue

Links on this page

view archives of Oser Communications Group - NACDS.TSE17.Aug22